Home › Cirrhosis › California › Los Angeles
Cirrhosis clinical trials in Los Angeles, CA
6 studies for Cirrhosis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
RecruitingPhase 3
- Velocity Clinical Research, Westlake, Los Angeles
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
RecruitingPhase 2
- Kaiser Permanente - Los Angeles Medical Center, Los Angeles
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RecruitingPhase 2
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
National Liver Cancer Screening Trial
RecruitingPhase 4
- University of Southern California, Los Angeles
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RecruitingObservational study
- Cedars-Sinai Comprehensive Transplant Center, Los Angeles
Danazol for Treatment of Cytopenias in Patients With Cirrhosis
RecruitingPhase 2
- Keck Hosital of USC, Los Angeles
About Cirrhosis
Cirrhosis is caused when scar tissue replaces healthy tissue in the liver because of chronic injury. Learn how cirrhosis is diagnosed and treated.
More about Cirrhosis on MedlinePlus
Cirrhosis trials in other cities
- Boston, MA10 studies
- Cleveland, OH9 studies
- Dallas, TX8 studies
- Houston, TX7 studies
- San Antonio, TX6 studies
- New York City, NY5 studies
- Miami, FL5 studies
- Chicago, IL4 studies
- Baltimore, MD4 studies
- Rochester, MN4 studies
- San Diego, CA4 studies
- Durham, NC4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.